Trans-catheter aortic valve implantation - Trans-catheter aortic valve implantation

Osaka University Graduate School of medicine Department of Cardiovascular Surgery, Department of Cardiology0 sites53 target enrollmentDecember 12, 2011

ConditionsSevere aortic valve stenosis

Overview

Phase: N/A
Intervention: Not specified
Conditions: Severe aortic valve stenosis
Sponsor: Osaka University Graduate School of medicine Department of Cardiovascular Surgery, Department of Cardiology
Enrollment: 53
Status: Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

December 12, 2011

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Osaka University Graduate School of medicine Department of Cardiovascular Surgery, Department of Cardiology

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1\. acute myocardial infarction within 1 month 2\. unicuspid, bicuspid aortic valve, or aortic valve stenosis without calcification 3\. severe aortic valve regurgitation 4\. cardiac intervention within 30 days (or intervention with drug eluting stent within 6 months) 5\.prior valve surgery with artifical valve, ring. or severe mitral valve regurgitation greater than 3\+/4\. 6\.leukopenia, acute anemia,thrombocytopenic purpura. or past history of coagulation disorder. 7\.coronary artery disease with significant stenosis requiring intervention. 8\. unstable circulation requiring mechanical support 9\.emergency procedure 10\.obstructive cardiomyopathy 11\. severe LV dysfunction (LVEF\<20%) 12\. cardiac tumor, thrombus, vegetation in UCG 13\. active gastrointestinal bleeding or history of upper gastrointestinal bleeding within 3 month 14\. allergy of aspirin, heparin, ticropigin, contrast medium. 15\. aortic valve annulus less than 16mm or larger than 24mm 16\. CVA or TIA within 6 months 17\. life expectancy less than 12 months by non\-cardiac disease 18\. involvement to another clinical trial 19\. inappropriate another factors (judged by cardiologist or cardiovascular surgeon)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed

N/A

Transcatheter aortic valve implantation for aortic stenosis registryAortic stenosis

JPRN-UMIN000023705Keio University Hospital800

Recruiting

N/A

TransCatheter Aortic Valve Implantation and Fractional Flow Reserve-Guided Percutaneous Coronary Intervention versus Conventional Surgical Aortic Valve Replacement and Coronary By-Pass Grafts for Treatment of Patients with Coronary MultiVessel Disease and Aortic Valve Stenosismeervatslijdenmultivessel disease and aortic valve stenosis10046973

NL-OMON50705Maatschap Cardiologie Zwolle170

Recruiting

N/A

Transcatheter Aortic Valve Implantation Registryof the University Heart Centre Freiburg - Bad KrozingeI35.0Aortic (valve) stenosis

DRKS00029242niversitätsklinikum Freiburg5,000

Completed

N/A

ew Transcatheter Aortic Valve Implantation (TAVI) GuidewireAortic stenosis, cardiovascular diseaseCirculatory SystemComplications and ill-defined descriptions of heart disease

ISRCTN29111908St George's, University of London (UK)20

Active, Not Recruiting

Phase 4

PMS plan is to provide local post marketing surveillance data regarding the safety of Medtronic CoreValveSystem FamilyHealth Condition 1: null- Symptomatic Aortic Stenosis

CTRI/2016/05/006957India Medtronic Pvt Ltd